| Identification | More | [Name]
4-(METHYLSULFONYLAMINO)PHENYLBORONIC ACID | [CAS]
380430-57-9 | [Synonyms]
4-METHANESULFONYLAMINOPHENYLBORONIC ACID
(4-METHYLSULFONYL)AMINOBENZENEBORONIC ACID
4-(METHYLSULFONYLAMINO)PHENYLBORONIC ACID
4-N-(METHANESULFONAMIDE)PHENYLBORONIC ACID
AKOS BRN-0584
N-4-METHANESULFONAMIDEPHENYLBORONIC ACID
Boronic acid, [4-[(methylsulfonyl)amino]phenyl]-(9CI)
4-(Methylsulphonyl)aminobenzeneboronic acid 95% | [Molecular Formula]
C7H10BNO4S | [MDL Number]
MFCD02179473 | [Molecular Weight]
215.03 | [MOL File]
380430-57-9.mol |
| Chemical Properties | Back Directory | [Melting point ]
148-154°C | [Boiling point ]
421.8±55.0 °C(Predicted) | [density ]
1.42±0.1 g/cm3(Predicted) | [storage temp. ]
Keep Cold | [form ]
solid | [pka]
8.42±0.10(Predicted) | [color ]
Beige | [InChI]
1S/C7H10BNO4S/c1-14(12,13)9-7-4-2-6(3-5-7)8(10)11/h2-5,9-11H,1H3 | [InChIKey]
NDVJJEADFLTFCD-UHFFFAOYSA-N | [SMILES]
CS(=O)(=O)Nc1ccc(cc1)B(O)O | [CAS DataBase Reference]
380430-57-9(CAS DataBase Reference) |
| Safety Data | Back Directory | [Symbol(GHS) ]
GHS07 | [Signal word ]
Warning | [Hazard statements ]
H302-H315-H319-H335 | [Precautionary statements ]
P261-P264-P270-P301+P312-P302+P352-P305+P351+P338 | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [WGK Germany ]
1 | [HS Code ]
2931900090 | [Storage Class]
11 - Combustible Solids | [Hazard Classifications]
Acute Tox. 4 Oral
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3 |
| Hazard Information | Back Directory | [Uses]
Reactant for preparation of:
- Potent and selective inhibitors of IKK-β
- Inhibitors for treatment of osteoporosis
- Inhibitors of human farnesyl pyrophosphate synthase
- Suzuki-type Pd(0) coupling reactions in the synthesis of 2-arylpurines as Cdk inhibitors
| [Uses]
Reactant for preparation of:• ;Potent and selective inhibitors of IKK-β1• ;Inhibitors for treatment of osteoporosis2• ;Inhibitors of human farnesyl pyrophosphate synthase3• ;Suzuki-type Pd(0) coupling reactions in the synthesis of 2-arylpurines as Cdk inhibitors4 |
|
|